Position in JNJ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$248,636
+$9,330 QoQ
Shares Held
979
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#4,344
of 4,664 holders
Holding Since
Dec 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stegent Equity Advisors, Inc. holds $2,590,515 across 4 Drug Manufacturers - General names. JNJ ranks #3 (9.6% of the industry book) .
All Filings in JNJ
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $248,636 | 979 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $239,306 | 979 | Shares | Sole | 2026-04-24 | |
| 2023-06-30 | $219,148 | 1,324 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $205,220 | 1,324 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $269,037 | 1,523 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $248,797 | 1,523 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $270,347 | 1,523 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $318,305 | 1,796 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $341,797 | 1,998 | Shares | Sole | 2022-02-08 | |
| No filing history on record for this holder in this stock. | ||||||